Data on timing of any serious adverse events Study Description An open label study to describe the safety and pharmacokinetics of intravenous acyclovir in premature infants with suspected systemic her
Background: Vancomycin-associated acute kidney injury (VA-AKI) is a recognizable condition with known risk factors. However, the use of vancomycin in clinical practices in China is distinct from other